MAPT and Alzheimer disease: Notably, TEAD1 is known to interact with ApoE, a key player in AD pathology and ApoE antibody inhibits Aβ-associated tau seeding and spreading in a mouse model [31], suggesting that TEAD1 may contribute to AD pathology through ApoE [32].